Urology Today.net

Site updated at Friday, 26 June 2015

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



fluid intake1 - estradiol deficiency1 - hemodiafiltration1 - low-calorie diet1 - diabetic kidney failure1 - multiple sclerosis1 - common kidney disease1 - anxiety1 - gonococcal infections1 - hormone therapy4 - kidney transplant15 - subacute1 - adolescent obesity1 - androgen receptor1 - kidney disease care1 - magnetic resonance prostate imaging reporting1 - mri -ultrasound1 - uterine fibroids1 - sexual changes1 - anorectal canal1 - sexual intercourse4 - thiazides1 - retrograde pyelography4 - albuminuria2 - radiotherapy3 - x-ray1 - pathologic fracture1 - tissue matching1 - prolapse1 - journal nature1 -